Topics and Expertise: HIV

PharmD students assess pharmacist furnishing of HIV medications under California's SB-159

Dong is a world expert on human immunodeficiency virus (HIV) and hepatitis C medication therapy

Jacqueline Kyosiimire-Lugemwa, the first recipient of QBI’s Scholarship for Women from Developing Nations in Biosciences, spent a year at UCSF in which her perseverance in the sciences was tested. She recently returned to her home country of Uganda more ready than ever to tackle big questions about...

A culture of discovery and collaboration among faculty carries potential to “completely shake up their fields of study.”

Nation debates possibility of dramatically new directions for health care coverage, science funding, immigration, education; Revealing malaria/HIV drug interactions in children; Decreasing cancer drug toxicity while increasing dose; Engineering safer opioids; Evidence for comprehensive medication...

Sub-Saharan Africa is home to a billion people and to overlapping health burdens, including the world’s highest rates of both malaria and HIV infection.

Charles S. Craik, PhD, faculty member in the School’s Department of Pharmaceutical Chemistry, has been named the 2016 recipient of the Protein Society’s Emil Thomas Kaiser Award.

New research support awarded to the UCSF School of Pharmacy by the National Institutes of Health during the 2011 fiscal year included these on-going projects by faculty in the Department of Clinical Pharmacy:

How do you convince patients who feel fine to take medicines that can have major side effects?

How can you help them stay on their lifesaving daily medications for years to come despite the obstacle course of everyday life?

Table of contents

Introduction
Budget significance
Reasons for past success
A decade of funding for bioinformatics
New drug discovery directions attract support
Research stalwarts draw funding for decades
New directions in translational research attract support
Expansion of the School’s...